Literature DB >> 24104687

RNA-seq analysis of antibiotic-producing Bacillus subtilis SC-8 in response to signal peptide PapR of Bacillus cereus.

In-Cheol Yeo1, Nam Keun Lee, Byung Wook Yang, Young Tae Hahm.   

Abstract

Bacillus subtilis SC-8 produces an antibiotic that has narrow antagonistic activity against bacteria in the Bacillus cereus group. In B. cereus group bacteria, peptide-activating PlcR (PapR) plays a significant role in regulating the transcription of virulence factors. When B. subtilis SC-8 and B. cereus are co-cultured, PapR is assumed to stimulate antibiotic production by B. subtilis SC-8. To better understand the effect of PapR on this interspecies interaction, the global transcriptome profile of B. subtilis SC-8 was analyzed in the presence of PapR. Significant changes were detected in 12.8 % of the total transcripts. Genes related to amino acid transport and metabolism (16.5 %) and transcription (15 %) were mainly upregulated, whereas genes involved in carbohydrate transport and metabolism (12.7 %) were markedly downregulated. The expression of genes related to transcription, including several transcriptional regulators and proteins involved in tRNA biosynthesis, was increased. The expression levels of genes associated with several transport systems, such as antibiotic, cobalt, and iron complex transporters, was also significantly altered. Among the downregulated genes were transcripts associated with spore formation, the subtilosin A gene cluster, and nitrogen metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24104687     DOI: 10.1007/s12010-013-0516-4

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  1 in total

1.  Inducible Antibacterial Activity in the Bacillales by Triphenyl Tetrazolium Chloride.

Authors:  Laura Sierra-Zapata; Javier C Álvarez; Magally Romero-Tabarez; Mark W Silby; Matthew F Traxler; Scott W Behie; Rita de Cassia Pessotti; Valeska Villegas-Escobar
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.